Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Q1 2025 Earnings Call Transcript
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Q1 2025 Earnings Call Transcript May 5, 2025Recursion Pharmaceuticals, Inc. misses on earnings expectations.
Recursion Pharmaceuticals Inc. (RXRX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | ARK Investment Management Catherine D. Wood | 34,815,502 | $184,174,004 | +8% | 1.84% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.82 | 66,822 | Large Shareholder | 12,985,927 | 2023-03-02 | Filing | |
| $7.94 | 48,867 | Large Shareholder | 12,919,105 | 2023-03-01 | Filing | |
| $7.97 | 815 | Large Shareholder | 12,870,238 | 2023-02-28 | Filing | |
| $7.69 | 52,500 | Large Shareholder | 12,869,423 | 2023-02-27 | Filing | |
| $7.64 | 109,118 | Large Shareholder | 12,816,923 | 2023-02-24 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.04 | 138,574 | Officer, Director | 1,117,450 | 2025-03-27 | Filing | |
| $6.37 | 20,000 | Officer, Director | 1,256,024 | 2025-03-06 | Filing | |
| $6.58 | 20,000 | Officer, Director | 1,256,024 | 2025-03-05 | Filing | |
| $8.12 | 20,000 | Officer, Director | 1,273,156 | 2025-02-06 | Filing | |
| $7.68 | 20,000 | Officer, Director | 1,273,156 | 2025-02-05 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 24,393,015 | $129,039,050 | 0.11% | |
| 2. | 23,506,589 | $124,349,857 | 0% | |
| 3. | 13,434,171 | $71,066,765 | 100% | |
| 4. | 8,479,284 | $44,855,412 | 0.03% | |
| 5. | 8,407,334 | $44,390,724 | 0.57% |
News See All
Did Jim Cramer Nail All These 9 Stock Predictions?
“When you see a grizzly bear in Yellowstone National Park, you call a park ranger because these bears are dangerous… but the grizzlies turn into teddy bears when the rangers come, and you can’t ...
Jim Cramer Hints at a Bigger Agenda Behind Tariffs and Breaks Down These 7 Stocks
In his latest appearance on CNBC’s Squawk on the Street, Jim Cramer suggested the recent tariffs might not simply be about economic leverage.
12 Best AI Stocks to Invest in According to Reddit
Jensen Huang had previously estimated that practical quantum computing would be 15 to 30 years away, but he recently revised this timeline to 5 to 15 years.
Jim Cramer's Latest Lightning Round: 8 Stocks in Focus
On Friday, Jim Cramer, host of Mad Money, addressed the current state of the stock market, giving a cautious recommendation to investors.
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Q4 2024 Earnings Call Transcript
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Q4 2024 Earnings Call Transcript February 28, 2025Recursion Pharmaceuticals, Inc. misses on earnings expectations.
10 Best Performing Pharma Stocks So Far in 2025
On February 20, Jared Holz, Mizuho healthcare sector strategist, appeared on 'Squawk Box' to discuss the potential challenges and opportunities the pharmaceutical industry may face under the new Trump...
10 Best Performing Healthcare Stocks So Far in 2025
Despite the ongoing craze surrounding the GLP-1 obesity drugs, the healthcare sector was a lagger last year.
Top 10 AI Stocks Buzzing on Latest News
Investors are continuing to assess the impact of new LLMs in the AI industry. X.
5 Stocks Jensen Huang's Company is Betting On
Nvidia has a reputation for identifying high-quality companies in their initial stages and betting on their success.
Billionaire Hedge Funds
